U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Method of assisting weight loss

Patent 4895845 Issued on January 23, 1990. Estimated Expiration Date: Icon_subject January 23, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

TCA Composition and method for rapid onset antidepressant therapy
Patent #: 4310524
Issued on: 01/12/1982
Inventor: Wiech ,   et al.

Long-term weight reduction of obese patients using femoxetine
Patent #: 4442113
Issued on: 04/10/1984
Inventor: Lassen ,   et al.

Treatment for selective weight control
Patent #: 4525359
Issued on: 06/25/1985
Inventor: Greenway, III ,   et al.

Treatment of obesity with aryloxyphenylpropylamines Patent #: 4626549
Issued on: 12/02/1986
Inventor: Molloy ,   et al.

Inventor

Application

No. 907837 filed on 09/15/1986

US Classes:

514/253.04, Bicyclo ring having the additional six-membered nitrogen hetero ring as one of the cyclos514/280, Pentacyclo ring system having the six-membered hetero ring as one of the cyclos514/649, Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain514/651, Ether oxygen is part of the chain514/910Anorectic

Examiners

Primary: Robinson, Douglas W.
Assistant: Henley, III, Raymond

Attorney, Agent or Firm

Foreign Patent References

  • 2048926 DE 04/13/1972

International Classes

A61K 031/50
A61K 031/495
A61K 031/44
A61K 031/135

Abstract

A method of assisting weight loss involving the combined administration of a rauwolfia alkaloid and at least one antidepressant, selected from the groups consisting of aminoazoles, phenoxyphenylpropylamines, and aminopropiophenones, in a daily regimen with the optional co-administration of one or more sympathomimetic anorexic agents. In a typical embodiment of this method, reserpine and trazodone are administered in a daily regimen with diethylpropion, fenfluramine or both diethylpropion and fenfluramine.

Other References

  • Science, 198:1178-1180--Wurtman et al
  • Chem. Abst. 88:130914d--Reinhard et al
  • The Merck Index--9th--1976--Items #396, and 3902
  • Goodman & Gilman--The Pharmacological Basis of Therapeutics, 6th Ed.--p. 17
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?